Literature DB >> 33296285

The emerging role of MEIS1 in cell proliferation and differentiation.

Mingzhu Jiang1,2, Shuang Xu1,2, Mi Bai1,2,3, Aihua Zhang1,2,3.   

Abstract

Cell proliferation and differentiation are the foundation of reproduction and growth. Mistakes in these processes may affect cell survival, or cause cell cycle dysregulation, such as tumorigenesis, birth defects and degenerative diseases, or cell death. Myeloid ecotropic viral integration site 1 (MEIS1) was initially discovered in leukemic mice. Recent research identified MEIS1 as an important transcription factor that regulates cell proliferation and differentiation during cell fate commitment. MEIS1 has a pro-proliferative effect in leukemia cells; however, its overexpression in cardiomyocytes restrains neonatal and adult cardiomyocyte proliferation. In addition, MEIS1 has carcinogenic or tumor suppressive effects in different neoplasms. Thus, this uncertainty suggests that MEIS1 has a unique function in cell proliferation and differentiation. In this review, we summarize the primary findings of MEIS1 in regulating cell proliferation and differentiation. Correlations between MEIS1 and cell fate specification might suggest MEIS1 as a therapeutic target for diseases.

Entities:  

Keywords:  MEIS1; cell proliferation; differentiation; glycolysis

Year:  2020        PMID: 33296285     DOI: 10.1152/ajpcell.00422.2020

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  3 in total

1.  A Novel SNP in the Promoter Region of IGF1 Associated With Yunshang Black Goat Kidding Number via Promoting Transcription Activity by SP1.

Authors:  Kunyu Li; Yufang Liu; Xiaoyun He; Lin Tao; Yanting Jiang; Rong Lan; Qionghua Hong; Mingxing Chu
Journal:  Front Cell Dev Biol       Date:  2022-05-12

2.  A stem cell marker KLF5 regulates CCAT1 via three-dimensional genome structure in colorectal cancer cells.

Authors:  Takashi Takeda; Yuhki Yokoyama; Hidekazu Takahashi; Daisuke Okuzaki; Kaho Asai; Hiroaki Itakura; Norikatsu Miyoshi; Shogo Kobayashi; Mamoru Uemura; Toshitsugu Fujita; Hiroo Ueno; Masaki Mori; Yuichiro Doki; Hodaka Fujii; Hidetoshi Eguchi; Hirofumi Yamamoto
Journal:  Br J Cancer       Date:  2021-10-27       Impact factor: 7.640

Review 3.  MEIS1 and its potential as a cancer therapeutic target (Review).

Authors:  Maozhong Yao; Yong Gu; Zhaoxin Yang; Keyan Zhong; Zhanjuan Chen
Journal:  Int J Mol Med       Date:  2021-07-28       Impact factor: 4.101

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.